Yixintang Pharmaceutical Group Co., Ltd. (002727) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Yixintang Pharmaceutical Group Co., Ltd.

Why is Yixintang Pharmaceutical Group Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 7.64% and Operating profit at -20.28% over the last 5 years

The company has declared Negative results for the last 7 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 1,924.6 MM
INTEREST COVERAGE RATIO(Q) Lowest at 143.21
NET SALES(Q) Lowest at CNY 4,086.54 MM

With ROE of 1.38%, it has a very attractive valuation with a 1.10 Price to Book Value

Over the past year, while the stock has generated a return of -3.27%, its profits have fallen by -72%
At the current price, the company has a high dividend yield of 3.6

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -3.27% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Yixintang Pharmaceutical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Yixintang Pharmaceutical Group Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Yixintang Pharmaceutical Group Co., Ltd.

-4.18%

-0.83

37.19%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.64%

EBIT Growth (5y)

-20.28%

EBIT to Interest (avg)

9.22

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

1.64

Tax Ratio

70.33%

Dividend Payout Ratio

155.68%

Pledged Shares

Institutional Holding

ROCE (avg)

12.89%

ROE (avg)

9.80%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.10

EV to EBIT

29.61

EV to EBITDA

4.73

EV to Capital Employed

1.10

EV to Sales

0.48

PEG Ratio

Dividend Yield

3.64%

ROCE (Latest)

3.72%

ROE (Latest)

1.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -1.89% (YoY

NET PROFIT(Q)

At CNY 18.38 MM has Grown at 73.45%

-8What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 1,924.6 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 143.21

NET SALES(Q)

Lowest at CNY 4,086.54 MM

OPERATING PROFIT(Q)

Lowest at CNY 46.76 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 1.14 %

Here's what is working for Yixintang Pharmaceutical Group Co., Ltd.

Net Profit

At CNY 18.38 MM has Grown at 73.45%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost

Fallen by -1.89% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Yixintang Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Lowest at CNY 1,924.6 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest Coverage Ratio

Lowest at 143.21

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales

Lowest at CNY 4,086.54 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 46.76 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 1.14 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Non Operating Income

Highest at CNY 0.64 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income